Latest Asx News

Lefroy Exploration has received a second $0.75 million cash advance from BML Ventures, reinforcing its funding position ahead of key production milestones at the Lucky Strike Gold Project.

Netwealth Group Limited will compensate members affected by the First Guardian Master Fund collapse with $101 million, impacting its 1H26 profit but aiming to restore member confidence swiftly.

FlexiRoam has launched Travel AI, the world’s first AI-powered eSIM agent integrated into WhatsApp, aiming to revolutionize how travellers and enterprises manage connectivity.

Equus Energy Limited launches a $15 million public offer to fund the acquisition and development of the Equus Gas Project in Western Australia, backed by conditional funding from Alcoa. The project boasts a large independently certified contingent gas resource, positioning the company to address looming supply shortfalls in domestic and LNG markets.

ActivEX Limited has raised $100,000 through a strategic share placement to Business Victor Investments, aiming to accelerate its exploration projects and strengthen working capital.

GenusPlus Group confirms the green light to commence a $140 million sub-transmission line construction for Ausgrid’s Hunter-Central Coast Renewable Energy Zone, starting February 2026.

Torque Metals has raised $16.2 million through a $15 million placement and early option exercises, setting the stage for an aggressive drilling campaign at its Paris Gold Project in Western Australia.

NTAW Holdings has secured an extension of its financial covenant waiver with Commonwealth Bank of Australia until March 2026, while continuing to reduce its borrowing facility.

RocketDNA has secured approximately A$1 million in new orders from major mining clients, expanding its autonomous drone deployments and software services across Australia and Africa.

Middle Island Resources has appointed Peter Spiers as CEO, aiming to accelerate exploration and development of its Serbian projects with his extensive industry expertise.

DEXUS has announced an estimated ordinary distribution of AUD 0.193 per unit for the six months ending December 2025, marking a steady income stream for investors ahead of the new year.

Anatara Lifesciences reports encouraging pre-clinical results for its anti-obesity candidate AOC, demonstrating significant reductions in weight regain and visceral fat in mice. However, a delay in mechanism of action studies pushes full data release to January 2026.